Flexible Treatment of Gestational Diabetes Mellitus Adjusted According to Intrauterine Fetal Growth Versus Treatment According to Strict Maternal Glycemic Parameters: a Randomized Clinical Trial

Overview

Journal BMJ Open Diabetes Res Care

Specialty Endocrinology

Date 2023 Jan 3

PMID 36593648

Authors

Manuela Fernandez-Lopez

Jose Eliseo Blanco-Carnero

Juan Manuel Guardia-Baena

Catalina de Paco-Matallana

Aurora Aragon-Alonso

Antonio Miguel Hernandez-Martinez

Affiliations

Soon will be listed here.

Abstract

Introduction: To compare the conventional treatment of gestational diabetes mellitus (GDM) with flexible treatment according to the measurement of fetal abdominal circumference (AC) in daily clinical practice.

Research Design And Methods: Two hundred and sixty pregnant women diagnosed with GDM before week 34 were randomly placed in two groups: a control group, treated according to maternal capillary glycemia, and an experimental group, treated according to ultrasound parameters of fetal growth. The glycemic targets in the control group were blood glucose levels when fasting and 1 hour postprandial (<95/140 mg/dL). In the experimental group, glycemic targets depended on the percentile (p) of fetal AC: if AC p <75th, then blood glucose targets when fasting and at 1 hour postprandial were <120/180 mg/dL; and if AC p ≥75th, then the glycemic targets were <80/120 mg/dL. The follow-up of both groups was scheduled according to the GDM protocol of our diabetes and gestation unit.

Results: The study was completed by 246 pregnant women, 125 in the control group and 121 in the experimental group. In the experimental group, insulin treatment and neonatal hypoglycemia were significantly lower (p=0.018 and p 0.035, respectively). No differences were observed in large and small infants according to gestational age. However, macrosomic infants were less frequent in the experimental group, although this difference did not reach statistical significance. In terms of gestation complications, the type of delivery and its complications and the rest of the neonatal complications analyzed, no significant differences were observed.

Conclusions: The treatment of flexible GDM according to the measurement of fetal AC is safe for the mother and the fetus and almost halves the number of pregnant women who require insulin treatment, without increasing the number of ultrasound checks or medical visits.

Citing Articles

Sample size calculation in clinical research.

Ranganathan P, Deo V, Pramesh C Perspect Clin Res. 2024; 15(3):155-159.

PMID: 39140012 PMC: 11318789. DOI: 10.4103/picr.picr_100_24.

References

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

Catalano P, Hauguel-De Mouzon S . Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?. Am J Obstet Gynecol. 2011; 204(6):479-87. PMC: 3130827. DOI: 10.1016/j.ajog.2010.11.039. View

Bonomo M, Cetin I, Pisoni M, Faden D, Mion E, Taricco E . Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab. 2004; 30(3):237-44. DOI: 10.1016/s1262-3636(07)70114-3. View

Carrascosa A . [Secular growth acceleration in Spain. Spanish growth studies 2010. Spanish-born population and immigrant population]. Endocrinol Nutr. 2014; 61(5):229-33. DOI: 10.1016/j.endonu.2014.03.004. View

Schaefer-Graf U, Kjos S, Fauzan O, Buhling K, Siebert G, Buhrer C . A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004; 27(2):297-302. DOI: 10.2337/diacare.27.2.297. View

Schaefer-Graf U, Kjos S, Buhling K, Henrich W, Brauer M, Heinze T . Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med. 2003; 20(5):349-54. DOI: 10.1046/j.1464-5491.2003.00946.x. View

. 14. Management of Diabetes in Pregnancy: . Diabetes Care. 2020; 44(Suppl 1):S200-S210. DOI: 10.2337/dc21-S014. View

Black M, Sacks D, Xiang A, Lawrence J . The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care. 2012; 36(1):56-62. PMC: 3526206. DOI: 10.2337/dc12-0741. View

Balsells M, Garcia-Patterson A, Gich I, Corcoy R . Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2013; 93(2):144-51. DOI: 10.1111/aogs.12291. View

10.

Kjos S, Schaefer-Graf U, Sardesi S, Peters R, Buley A, Xiang A . A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001; 24(11):1904-10. DOI: 10.2337/diacare.24.11.1904. View

11.

Landon M, Spong C, Thom E, Carpenter M, Ramin S, Casey B . A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14):1339-48. PMC: 2804874. DOI: 10.1056/NEJMoa0902430. View

12.

Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991-2002. DOI: 10.1056/NEJMoa0707943. View

13.

Kjos S, Schaefer-Graf U . Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care. 2008; 30 Suppl 2:S200-5. DOI: 10.2337/dc07-s216. View

14.

Buchanan T, Kjos S, Montoro M, Wu P, Madrilejo N, Gonzalez M . Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994; 17(4):275-83. DOI: 10.2337/diacare.17.4.275. View

15.

Snijders R, Nicolaides K . Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol. 1994; 4(1):34-48. DOI: 10.1046/j.1469-0705.1994.04010034.x. View

16.

WEISS P, Hofmann H, Winter R, Lichtenegger W, Purstner P, Haas J . Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol. 1986; 239(2):81-91. DOI: 10.1007/BF02133967. View

17.

. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979; 28(12):1039-57. DOI: 10.2337/diab.28.12.1039. View

18.

Pedersen J, Osler M . Hyperglycemia as the cause of characteristic features of the foetus and newborn of diabetic mothers. Dan Med Bull. 1961; 8:78-83. View

19.

Rossi G, Somigliana E, Moschetta M, Bottani B, Barbieri M, Vignali M . Adequate timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study. Acta Obstet Gynecol Scand. 2000; 79(8):649-54. View

20.

Rao U, de Vries B, Ross G, Gordon A . Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Cochrane Database Syst Rev. 2019; 9:CD012544. PMC: 6718273. DOI: 10.1002/14651858.CD012544.pub2. View